Gene · 554
NIH grants1,257
NIH grants whose papers are about the gene, through NIH's grant-paper links.
361 to 380 of 1,257
Download this page as JSON| Grant | Title | AVPR2 papers | Newest fiscal year |
|---|---|---|---|
| R35GM122491 | Targeted Engineering of Designer Arrestins to Regulate Cell Signaling | 6 | 2021 |
| R01GM130142 | Direct assessment of GPCR-transducer coupling and G protein subtype bias | 5 | 2021 |
| T32GM007171 | Medical Scientist Training Program | 5 | 2021 |
| F30GM131672 | Contributions of Gα Subunit Distal Helix 5 to GPCR-G Protein Selectivity | 2 | 2021 |
| P50CA097274 | Lymphoma Specialized Program of Research Excellence (SPORE) in Human Cancer | 2 | 2021 |
| R01DC015784 | Inhibitory processing and social learning in the mouse accessory olfactory bulb | 2 | 2021 |
| R01DK115976 | Role of Brown Adipose Tissue Thermogenesis in Oxytocin-Elicited Weight Loss | 2 | 2021 |
| R35CA197697 | Mechanisms of regulation by RNA in acute myeloid leukemia | 2 | 2021 |
| R37DA008863 | Post-translational regulation of opioid and cannabinoid receptors | 2 | 2021 |
| T32GM007315 | Cellular and Molecular Biology at Michigan | 2 | 2021 |
| U54CA209891 | Research Center for Cancer Systems Biology: Cancer Cell Map Initiative | 2 | 2021 |
| ZIAHD008920 | Molecular Genetics of Endocrine Tumors and Related Disorders | 2 | 2021 |
| DP1HL141201 | Exploration of Diverse Mobile Genetic Elements for Precision Genome Manipulation | 1 | 2021 |
| F30HD097925 | The effects of oxytocin receptor genetic variants on oxytocin response | 1 | 2021 |
| F31DK129004 | Multi-modal single cell analysis for investigation of T1D pathogenesis | 1 | 2021 |
| F32NS106740 | Regionalized Human Motor Neuron Therapies | 1 | 2021 |
| I01BX002228 | Renal Effects of Aldosterone | 1 | 2021 |
| I01BX003453 | A novel treatment for bone fracture repair | 1 | 2021 |
| I01BX003480 | Regulation of neuro-cardiovascular function during stress | 1 | 2021 |
| K01AT009373 | Epigenetic mechanisms of maternal diets in human health and disease prevention | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/grants?page=19